Moti Ramgopal

Countries

This corpus build does not record which country the citing authors are in, so the country breakdown is not computed. The other breakdowns below are unaffected.

Institutions

• Gilead Sciences (United States)16.5%
• University of California, San Francisco9.4%
• Johns Hopkins University8.1%
• Centre Hospitalier de l’Université de Montréal7.6%
• Merck & Co., Inc., Rahway, NJ, USA (United States)7.4%
• Inserm7%
• Other44%

Fields

• Medicine71.5%
• Immunology and Microbiology25%
• Biochemistry, Genetics and Molecular Biology1.6%
• Health Professions0.4%
• Chemistry0.3%
• Computer Science0.3%
• Other1%

Topics

• HIV/AIDS drug development and treatment25.1%
• HIV Research and Treatment22.9%
• HIV/AIDS Research and Interventions17.2%
• HIV-related health complications and treatments11.4%
• Immune Cell Function and Interaction4.6%
• Hepatitis C virus research3.3%
• Other15.5%